| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $0 | — | — |
| SG&A Expense | $5K | +16.1% | +19.6% |
| Operating Income | -$95K | +15.5% | -603.1% |
| Pre-tax Income | -$94K | +15.6% | -600.7% |
| Income Tax | $0 | — | — |
| Net Income | -$94K | +15.6% | -600.7% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $57K | +314.1% | — |
| Current Assets | $57K | +314.1% | — |
| Total Assets | $443K | +208.3% | — |
| Current Liabilities | $807K | +5.0% | -66.8% |
| Total Liabilities | $807K | +5.0% | -66.8% |
| Stockholders' Equity | -$364K | +41.8% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$109K | — | — |
| Capital Expenditures | $208K | — | — |
| Investing Cash Flow | -$208K | — | — |
| Financing Cash Flow | $378K | — | — |
| Free Cash Flow | -$316K | — | — |
| +85.0% |